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Synthesis and structure elucidation of some novel thiophene and 
benzothiophene derivatives as cytotoxic agents
Att empting to produce cyclized systems with potential 
anti-proliferative activity, a series of novel thiophene and 
benzothiophene derivatives were designed and synthe-
sized. The reactivity of the latt er derivatives towards diff er-
ent chemical reagents was studied. Twenty-one compounds 
were synthesized and evaluated as anti-cancer agents. The 
results showed that ethyl 5-amino-3-(4-chlorostyryl)-4-cy-
anothiophene-2-carboxylate (5b), ethyl 5-amino-4-((4-me-
thoxyphenyl)carbonyl)-3-methylhiophene-2-carboxylate 
(8c) and 5-3-(ethoxy-3-oxopropanamido)-3-methyl-4-
(phenylcarbamoyl)thiophene-2-carboxylate (9) were the 
most active compounds towards three tumor cell lines – 
MCF-7 (breast adenocarcinoma), NCI-H460 (non-small cell 
lung cancer) and SF-268 (CNS cancer) and a normal fi bro-
blast human cell line (WI-38) compared to the anti-prolifer-
ative eff ects of the reference control doxorubicin.
Keywords: thiophene, benzothiophene, cytotoxic agents
Thiophene derivatives are a very important class of compounds with diff erent uses, 
including industrial and medicinal chemistry (1–4). Further, substituted and fused thio-
phenes showed interesting applications in the fi eld of medicinal chemistry (5–11).
On the other hand, benzo[b]thiophenes (12) are naturally occurring heterocyclic com-
pounds (13) with diverse applications in medicinal chemistry and material science, att ract-
ing great interest in industry as well as academia. They display a wide range of biological 
and physiological functions such as anti-infl ammatory (14), anti-fungal (15), anti-depres-
sant (16), estrogen receptor modulating (17), anti-mitotic (18), kinases inhibiting (19, 20) and 
anti-cancer (21, 22). Several commercially available drugs, such as sertaconazole nitrate 
and benocyclidine, contain the benzo[b]thiophene core structure as well.
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All melting points were determined on an Electrothermal digital melting point ap-
paratus and are uncorrected. IR spectra (KBr discs) were recorded on a FTIR plus 460 or 
Pye Unicam SP-1000 spectrophotometer (Pye Unicam, UK). 1H NMR and 13C NMR spectra 
were recorded with Varian Gemini-200 (200 MHz, Varian UK) and Jeol AS 500 MHz (Jeol, 
Japan) instruments in DMSO-d6 as a solvent, using TMS as internal standard. Chemical 
shift s are expressed as d ppm. The mass spectra were recorded with a Hewlett  Packard 
5988 A GC/MS system (Hewlett  Packard, Agilent, USA) and GCMS-QP 1000Ex Shimadzu 
(EI, 70 eV) (Japan) instruments. Analytical data were obtained from a Vario EL III Elemen-
tal CHNS analyzer (Germany).
Syntheses
Ethyl 5-amino-4-cyano-3-methylthiophene-2-carboxylate (1a) and diethyl 5-amino-3-methyl-
thiophene-2,4-dicarboxylate (1b). General procedure. – Equimolar amounts of ethyl acetoace-
tate (1.30 g, 0.01 mol) and elemental sulfur (0.32 g, 0.01 mol) containing a catalytic amount 
of triethylamine in ethanol (25 mL), either malononitrile (0.66 g, 0.01 mol) or ethyl cyano-
acetate (1.13 g, 0.01 mol), were added. The reaction mixture in each case was heated under 
refl ux for 3 hours, then cooled and neutralized by pouring into an ice/water mixture con-
taining a few drops of hydrochloric acid. The solid product formed in each case was col-
lected by fi ltration and crystallized from ethanol to give 1a and 1b, respectively (Table I).
Ethyl 5-(acetylamino)-4-cyano-3-methylthiophene-2-carboxylate (2). – A solution of 1a (2.10 
g, 0.01 mol) in acetic acid/acetic anhydride (10:3 mL) was heated under refl ux for 3 hours. 
The solid product formed upon pouring into an ice/water mixture was collected by fi ltra-
tion, washed with water and crystallized from ethanol to give 2 (Table I).
Ethyl 5-amino-4-cyano-3-((2-phenylhydrazinylidene)methyl) thiophene-2-carboxylate (3a), 
ethyl 5-amino-3-(2-(4-chlorophenyl)hydrazinylidene)-methyl-4-cyanothiophene-2-carboxylate 
(3b), ethyl 5-amino-4-cyano-3-[2-(4-methoxyphenyl)hydrazinylidene]-methyl thiophene-2-carbox-
ylate (3c) and ethyl 5-amino-4-cyano-3-(2-(4-methylphenyl)hydrazinylidene)methylthiophene-2-
carboxylate (3d). General procedure. – To a cold solution (0–5 oC) of 1a (2.10 g, 0.01 mol) in 
ethanol (98 %, 20 mL) containing sodium hydroxide (10 %, 5 mL), an equimolar amount of 
either diazotized aniline (0.93 g, 0.01 mol), diazotiazed 4-chloroaniline (1.27 g, 0.01 mol), 
diazotiazed 4-methoxyaniline (1.23 g, 0.01 mol) or diazotiazed p-toluidene (1.07 g, 0.01 mol) 
[the corresponding diazonium salt, in each case, was prepared by adding a NaNO2 (0.70 g, 
0.01 mol) solution to a cold solution (0–5 °C) of either aniline, 4-chloroaniline, 4-methoxy-
aniline or p-toluidene in concentrated hydrochloric acid (18 μmol L–1, 5 mL) under con-
tinuous stirring] was gradually added under stirring. The solid products formed upon 
cooling in an ice bath were collected by fi ltration, washed with water and crystallized from 
ethanol to give 3a-d, respectively (Table I).
Ethyl 4-cyano-5-((2,2-dicyanoethylidene)amino)-3-methylthiophene-2-carboxylate (4). – To a 
mixture of 1a (2.10 g, 0.01 mol) and ethyl orthoformate (1.48 g, 0.01 mol), a catalytic amount 
of piperidine was added and the reaction mixture was heated in an oil bath at 120 °C for 2 
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hours. The mixture was then boiled in ethanol for a few minutes, poured onto an acidifi ed 
ice/water mixture and the product was crystallized from ethanol to give 4 (Table I).
Ethyl 5-amino-4-cyano-3-styrylthiophene-2-carboxylate (5a), ethyl 5-amino-3-(4-chlorostyryl)-
4-cyanothiophene-2-carboxylate (5b), ethyl 5-amino-4-cyano-3-[2-(2-methoxyphenyl)-ethenyl]thio-
phene-2-carboxylate (5c) and ethyl 5-amino-4-cyano-3-[2-(2-hydroxypentyl)ethenyl]thiophene-car-
boxylate (6). General procedure. – To a solution of 1a (2.10 g, 0.01 mol) containing a catalytic 
amount of piperidine (0.5 mL), either benzaldehyde (1.06 g, 0.01 mol), 4-chlorobenzaldehyde 
(1.40 g, 0.01 mol), 4-methoxybenzaldehyde (1.36 g, 0.01 mol) or salicyaldehyde (1.22 g, 0.01 mol) 
was added and heated in an oil bath at 120 oC for about 2 hours, then boiled in ethanol (20 mL) 
for a few minutes. The solid products obtained upon pouring into an acidifi ed ice/water 
mixture were crystallized from ethanol to give 5a-c and 6, respectively (Table I).
Ethyl 3,6-diamino-5-cyano-4-hydroxybenzo[c]thiophene-1-carboxylate (7). – To a solution of 
1b (2.57 g, 0.01 mol) in 1,4-dioxane (25 mL) containing a catalytic amount of triethylamine, 
malononitrile (0.66 g, 0.01 mol) was added. The reaction mixture was heated under refl ux 
for 3 hours, then cooled and neutralized by pouring into an ice/water mixture containing 
a few drops of hydrochloric acid. The solid product formed was collected by fi ltration and 
crystallized from 1,4-dioxane to give 7 (Table I).
2-Ethyl 5-amino-3-methyl-4-(phenylcarbamoyl)thiophene-2-carboxylate (8a), ethyl 5-amino-
3-methyl-4-(p-tolylcarbamoyl)thiophene-2-carboxylate (8b) and ethyl 5-amino-4-((4-methoxyphe-
nyl)carbamoyl)-3-methylthiophene-2-carboxylate (8c). General procedure. – To a solution of either 
2-cyano-N-phenylacetamide (1.60 g, 0.01 mol), 2-cyano-N-(p-tolyl)acetamide (1.74 g, 0.01 
mol) or N-(4-methoxyphenyl)-2-cyanoacetamide (1.90 g, 0.01 mol) [prepared by adding 
ethyl cyanoacetate (1.13 g, 0.01 mol) to either aniline (0.93 g, 0.01 mol), p-toludiene (1.07 g , 
0.01 mol) or 4-methoxyaniline (1.23 g, 0.01 mol) under refl ux for 2 hours, then poured into 
an ice/water mixture and collected by fi ltration] in ethanol (25 mL) containing a catalytic 
amount of triethylamine (0.50 mL), ethyl acetoacetate (1.30 g, 0.01 mol) and elemental sul-
fur (0.32 g, 0.01 moL) were added. The reaction mixture was heated under refl ux for 5 
hours, then cooled, and neutralized by pouring into an acidifi ed ice/water mixture. The 
solid product formed in each case was fi ltered off  and crystallized from ethanol to give 
8a-c, respectively (Table I).
Ethyl 5-(3-ethoxy-3-oxopropanamido)-3-methyl-4-(phenylcarbamoyl)thiophene-2-carboxyl-
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0.01 mol) in dimethylformamide (20 mL) were heated under refl ux for 5 hours. The solid 
product formed upon pouring into an ice/water mixture was collected by fi ltration and 
crystallized from dimethylformamide to give 9 (Table I).
Ethyl 3,6-diamino-5-cyano-4-(phenylamino)benzo[c]thiophene-1-carboxylate (10a) and di-
ethyl 3,6-diamino-4-(phenylamino)benzo[c]thiophene-1,5-dicarboxylate (10b). General procedure. 
– To a solution of 8a (3.04 g, 0.01 moL) in 1,4 dioxane (25 mL) and dimethylformamide 
(15 mL) containing a catalytic amount of triethylamine, either malononitrile (0.66 g, 0.01 
mol) or ethyl cyanoacetate (1.13 g, 0.01 mol) was added. The reaction mixture was heated 
under refl ux for 5 hours. Aft er cooling, the reaction mixture, in each case, was acidifi ed by 
a few drops of hydrochloric acid (18 mol L–1, 0.50 mL) and the crude product was precipi-
tated, collected by fi ltration and crystallized from 1,4-dioxane to give 10a and 10b, respec-
tively (Table I).
Ethyl 5-acetamido-3-methyl-4-(phenylcarbamoyl)thiophene-2-carboxylate (11). – A solution 
of 8a (3.04 g, 0.01 mol) in acetic acid/acetic anhydride (10:3 mL) was heated under refl ux for 
3 hours. The solid product formed upon pouring into an ice/water mixture was collected 
by fi ltration, washed with water and crystallized from ethanol to give 11 (Table I).
Ethyl 5-amino-4-(phenylcarbamoyl)-3-styrylthiophene-2-carboxylate (12). – A solution of 8a 
(3.04 g, 0.01 mol) containing a catalytic amount of piperidine (0.50 mL) and benzaldehyde 
(1.06 g, 0.01 mol) was heated in an oil bath at 120 °C for about 2 hours and then boiled in 
ethanol (20 mL) for a few minutes. The solid product obtained upon pouring into an acid-
ifi ed ice/water mixture was crystallized from ethanol to give 12 (Table I).
In vitro cytotoxic activity of the newly synthesized compounds
Fetal bovine serum (FBS) and L-glutamine were obtained from Gibco Invitrogen 
Company (UK). RPMI-1640 medium was provided by Cambrex (USA). Dimethyl sulfoxide 
(DMSO), doxorubicin, penicillin, streptomycin and sulforhodamine B (SRB) were obtained 
from Sigma Chemical Company (USA).
Stock solutions of compounds 1 to 12 were pre pared in DMSO and kept at −20 °C. Ap-
propriate dilutions of the compounds were freshly prepared just prior to assays. Final 
concentrations of DMSO did not interfere with cell growth.
Three human tumor cell lines, MCF-7 (breast adenocarcinoma), NCI-H460 (non-small 
cell lung cancer), and SF-268 (CNS cancer), were used. MCF-7 was obtained from the Euro-
pean Collection of Cell Cultures (ECACC, Salisbury, UK) and NCI-H460 and SF-268 were 
kindly provided by the National Cancer Institute (NCI, Cairo, Egypt). They grew as mono-
layers and were routinely maintained in RPMI-1640 medium supplemented with 5 % heat- 
-inactivated FBS, 2 mmol L–1 glutamine and antibiotics (penicillin 100 g mL–1, streptomycin 
100 μg mL–1), at 37 °C in a humidifi ed atmosphere containing 5 % CO2. Exponentially growing 
cells were obtained by plating 1.5 × 105 cell mL–1 for MCF-7 and SF-268 and 0.75 × 104 cell mL–1 
for NCI-H460, followed by 24 h of incubation. The eff ect of the vehicle solvent (DMSO) on 
the growth of these cell lines was evaluated in all the experiments by exposing untreated 
control cells to the maximum concentration (0.5 %) of DMSO used in each assay and the 
results are given in Table III. 
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MCF-7 NCI-H460 SF-268 WI-38
1 a 40.0 ± 1.8 44.3 ± 10.8 20.5 ± 1.1 10.3 ± 2.8
1b 2.0 ± 1.2 2.6 ± 1.4 4.4 ± 0.8 80.3 ± 18.4
2 4.6 ± 2.4 2.9 ± 0.8 1.8 ± 0.6 40.2 ± 10.2
3a 13.8 ± 0.6 16.5 ± 0.8 16.7 ± 1.6 > 100
3b 22.0 ± 0.2 30.6 ± 1.7 38.4 ± 0.6 30.1 ± 4.6
3c 36.7 ± 17.5 42.2 ± 12.8 54.0 ± 9.0 43.5 ± 8.2
3d 20.0 ± 0.6 22.0 ± 0.4 31.5 ± 8.0 58.2 ± 12.7
4 44.6 ± 12.2 32.6 ± 8.6 60.4 ± 14.8 12.3 ± 6.1
5a 0.6 ± 0.2 0.1 ± 0.02 0.3 ± 0.05 22.8 ± 8.0
5b 0.03 ± 0.007 0.02 ± 0.008 0.01 ± 0.004 > 100
5c 38.0 ± 1.8 44.0 ± 4.5 20.5 ± 1.1 68.2 ± 12.9
6 23.6 ± 0.4 24.3 ± 0.8 32.0 ± 0.8 4.2 ± 1.8
7 28.0 ± 4.6 20.0 ± 2.4 33.5 ± 6.0 36.2 ± 6.9
8a 35.4 ± 10.2 24.1 ± 0.8 18.9 ± 6.8 44.1 ± 6.3
8b 38.0 ± 1.8 12.0 ± 0.8 16.5 ± 4.1 36.6 ± 4.7
8c 0.01 ± 0.006 0.03 ± 0.002 0.06 ± 0.005 > 100
9 0.01 ± 0.003 0.02 ± 0.001 0.01 ± 0.001 66.5 ± 12.7
10a 30.1 ± 0.6 17.3 ± 1.4 22.3 ± 1.5 60.5 ± 22.6
10b 28.0 ± 0.2 30.6 ± 1.4 38.4 ± 0.6 44.3 ± 10.6











Doxorubicin 0.0428 ± 0.0082 0.0940 ± 0.0087 0.0940 ± 0.0070 > 100
a Drug concentration required to inhibit tumor cell proliferation by 50 % aft er continuous exposure of 48 h; data are 
expressed as mean ± SEM of three independent experiments performed in duplicates.
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In the present work, we are demonstrating the synthesis of thiophene derivatives to-
gether with their cytotoxic evaluation, in continuation of our interest in the design of bio-
active heterocycles (23–27). Thus, the reaction of ethyl acetoacetate with elemental sulphur 
and either malononitrile or ethyl cyanoacetate gave the thiophene derivatives 1a,b, respec-
tively. The structures of the products were based on analytical and spectral data. Thus, the 
1H NMR spectrum of 1a showed a singlet at d1.18 ppm for the CH3 group, a triplet at d1.23 
ppm and a quartet at d4.15–4.18 ppm indicating ethoxy group and a singlet atd 7.93 ppm 
(D2O exchangeable) equivalent to the NH2 group. The 2-amino group present in compound 
1a was capable of acetylation. Thus, compound 1a reacted with acetic anhydride to give 
the N-acetyl derivative 2. 
On the other hand, the methyl group, which is in the ortho-position to the cyano group 
present in compound 1a, showed interesting reactivity towards some reagents. Thus, com-
pound 1a reacted with either benzene-diazonium chloride, 4-chlorobenzene, 4-methoxy-
benzene or 4-methylbenzene diazonium chloride to give the arylhydrazone derivatives 
3a-d, respectively. 
Next, we studied the reaction of the thiophene derivative 1a with each ethyl orthofor-
mate and malononitrile. The reaction was carried out in a catalytic amount of piperidine 
to aff ord the N-methinomalononitrile derivative 4 (Scheme 1). The structure of compound 
4 was based on analytical and spectral data. Thus, the 1H NMR spectrum showed a singlet 
at d1.63 ppm corresponding to the CH3 group, a triplet atd 1.30 ppm equivalent to the 
ester CH3 group, a quartet at d4.17 ppm for the ester CH2 group and two singlets at d4.00 
and d6.80 ppm for the two CH groups.
Compound 1a reacted with either benzaldehyde, 4-chlorobenzaldehyde or 4-me-
thoxybenzaldehyde to give the benzal derivatives 5a-c, respectively. Similarly, the reaction 
of 1a with salicyladehyde gave the o-hydroxybenzal derivative 6. The analytical and spec-
tral data of compounds 5a-c and 6 were consistent with their respective structures. On the 
other hand, the reaction of 1b with malononitrile gave ethyl 3,6-diamino-5-cyano-4-
hydroxybenzo[c]thiophen-1-carboxylate 7 (Scheme 2). The analytical and spectral data of 
the latt er product were the tools of its structural elucidation. Thus, the 1H NMR spectrum 
showed a triplet at d1.16–1.18 ppm corresponding to the ester CH3 group, a quartet at 
d 4.18–4.23 ppm for the ester CH2 group, a singlet indicating CH benzene ring at d7.89 
ppm, two singlets at d 7.10 and 9.10 ppm (D2O exchangeable) indicating the two NH2 groups 
and a singlet for the OH group atd 14.23 ppm.
At the other extreme, ethyl acetoacetate reacted with elemental sulfur and either 2-cy-
ano-N-phenylacetamide, 2-cyano-N-(p-tolyl)acetamide, or N-(4-methoxyphenyl)-2-cyano-
acetamide in the presence of ethanol containing a catalytic amount of triethylamine to give 
the thiophene derivatives 8a-c. Mass spectra of 8a-c displayed [M+] ion peaks and [M+-1] at 
m/z 304, 318 and 333, respectively, corresponding to their respective molecular formulae 
C15H16N2O3S, C16H18N2O3S and C16H18N2O4S.
The 2-amino group present in 8a was capable of amide formation; thus, the reaction 
of 8a with diethylmalonate gave the (3-ethoxy-3-oxopropanamido)thiophene derivative 9. 
On the other hand, the reaction of 8a with either malononitrile or ethyl cyanoacetate in 
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refl uxing 1,4-dioxane containing a catalytic amount of triethylamine gave the benzo[c]
thiophene derivatives 10a and 10b, respectively. The 1H NMR and 13C NMR spectra were 
the basis of their structure elucidation. The reaction of compound 8a with acetic anhydride 
gave the N-acetyl derivative 11. 
Moreover, the reaction of compound 8a with benzaldehyde gave the benzalidene de-
rivative 12 (Scheme 3). The structure of compound 12 was based on analytical and spectral 
data. Thus, the 1H NMR spectrum showed a triplet for the ester CH3 group d1.18–1.21 ppm, 
two singlets atd 4.15 and 4.17 ppm equivalent to the benzal CH, a quartet d4.64–4.76 ppm 
for the ester CH2 group, a multiplet at d 7.12–8.10 ppm for the benzene ring and two singlets 
at d8.29 and 10.41 ppm for NH2 and NH groups, respectively. Mass spectrum of compound 
12 showed m/z 391 [M+-1] and m/z 77 [C6H5]+ for phenyl moiety.
In vitro cytotoxic activity of the newly synthesized compounds
The tumor cell growth inhibition activities of the newly synthesized thiophene systems 
(21 compounds in total) were assessed in vitro (28, 29) on three human tumor cell lines, 
namely, MCF-7 (breast adenocarcinoma), NCI-H460 (non-small cell lung cancer), SF-268 
(CNS cancer), and normal fi broblast cells (WI-38), aft er continuous exposure for 48 h. The 
results were compared to the anti-proliferative eff ects of the reference control doxorubicin 
Scheme 1
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Scheme 2
(30). All compounds were dissolved in DMSO with the maximum concentration 0.5 % in 
each assay.
The ± SEM means of three independent experiments performed in duplicate.
The results from Table III indicate that most of the compounds demonstrated substan-
tial growth inhibitory eff ects against the human tumor cells at the concentrations tested. 
The anti-proliferative activity of the test compounds against each of the title tumor cell 
lines may be arranged in a descending according to the measured concentration required 
to inhibit tumor cell proliferation by 50 %.
It is clear from Table III that compounds 5b, 8c and 9 showed signifi cant activity 
against the three tumor cell lines tested. The inhibitory eff ects of other compounds varied, 
depending on the tested tumor cell, from high to medium or marginal eff ects. Some com-
pounds had no impact on a specifi c tumor cell proliferation, but exhibited some specifi city 
to another. 
Structure activity relationship
It is obvious that compounds 5b, 8c and 9 exhibited maximal cytotoxic eff ect against 
cancer cell lines, with IC50’s in the μmol L–1 range. Comparing the cytotoxicity of thiophene 
derivatives 1a and 1b, it is clear that the cytotoxicity of 1b is higher than that of 1b. The 
presence of the ethoxy group is responsible for the higher potency of 1b. Acetylation of 
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Scheme 3
compound 1a gave the N-acetyl derivative 2, for which the cytotoxicity apparently in-
creased. As regards the arylhydrazone derivatives 3a-d, it is clear that the unsubstituted 
aryl derivatives showed the highest cytotoxicity among the four compounds. On the other 
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hand, the reaction of compound 1a with malononitrile and ethyl orthoformate to give 
compound 4 resulted in a remarkable decrease of cyctotoxicity. Moreover, it is obvious for 
the benzalthiophene derivatives 5a-c that compound 5b showed high cytotoxicity due to 
the presence of the chloro group. The reaction of 1a with either salicylaldehyde or malonon-
itrile gave compound 6 or 7, respectively, which showed a moderate increase in their cyto-
toxicity. On the other hand, it is clear for the other series of the thiophene amide deriva-
tives 8a, 8b and 8c that the presence of the OCH3 group in compound 8c is responsible for 
higher cytotoxicity than that of compound 8b, which bears the CH3 group. Moreover, 
compound 9 revealed higher cytotoxicity than doxorubicin; such high cytotoxicity was 
att ributed to the presence of two ethoxy groups. It is clear from Table III that the thiophene 
derivatives 10a, 10b and 11 showed moderate cytotoxicity. It is noteworthy that the reac-
tion of compound 8a with benzaldehyde to give benzylidine derivative 12 resulted in re-
markable increase in cytotoxicity. Our results showed that, in most cases, the electronega-
tive Cl, OCH3 and OC2H5 hydrophobic groups in the thiophene derivatives might play a 
very important role in enhancing the cytotoxic eff ect. It is clear from Table III that com-
pounds 1a, 4 and 6 showed cytotoxicity against the normal cell line WI-38 and low po-
tency against the cancer cell lines. 
CONCLUSIONS
In summary, we have developed a convenient synthetic approach for novel thiophene 
and benzothiophene derivatives. The region selective att ack by diff erent reagents on the 
active center moiety in the thiophene system led to the diversity of the produced systems. 
Most of the newly synthesized compounds were found to be promising anti-proliferative 
agents. Results showed that ethyl 5-amino-3-(4-chlorostyryl)-4-cyanothiophene-2-carbox-
ylate (5b), ethyl 5-amino-4-[(4-methoxyphenyl)carbamoyl]-3-methylthiophene-2-carboxyl-
ate (8c) and ethyl 5-(3-ethoxy-3-oxopropanamido)-3-methyl-4-(phenylcarbamoyl)thio-
phene-2-carboxylate (9) are the most active compounds against the three tumor cell lines 
such as MCF-7, NCI-H460 and SF-268. At the same time, they showed low potency against 
the normal fi broblasts human cell line (WI-38). On the other hand, compounds 1a, 4 and 6, 
although showing low potency against the cancer cell lines, showed high potency against 
the normal fi broblasts (WI-38) cell lines.
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